Tudorza Pressair is a long-term maintenance treatment of bronchospasms associated with chronic obstructive pulmonary disease (COPD). It is not a rescue medicine and should not be used for treating sudden breathing problems. Tudorza Pressair belongs to a class of drugs known as anticholinergics that works to inhibit the effects of acetylcholine, a neurotransmitter. It transfers signals between certain cells and affects bodily functions.
What are the ingredients in Tudorza Pressair?
The active ingredient in Tudorza Pressair is aclidinium bromide, a long-acting muscarinc agent (LAMA) or anticholinergic. One oral inhalation contains 400mcg of aclidinium bromide.
How does Tudorza Pressair work?
Tudorza Pressair works by relaxing the muscles that surround the airways. For people living with COPD, the muscles lining the airways can tighten causing the airways to become too narrow therefore making breathing difficult. This is known as a bronchospasm.
What are the possible side effects of Tudorza Pressair?
For patients in clinical trials that were treated with Tudorza Pressair, side effects included:
Patients should stop treatment and consult their doctor immediately if:
They experience sudden worsening of breathing problems
They experience an allergic reaction, such as hives, rash, trouble breathing and swallowing
Patients with urinary retention (difficult and painful urination) and glaucoma (eye pain/redness, blurred vision, vision changes) may experience worsening of symptoms and should consult their doctors immediately if any of these signs develop. These are not all the possible side effects of Tudorza Pressair. Patients should talk to their doctor about what to expect with treatment with Tudorza Pressair.
Things to know about Tudorza Pressair
Patients who are allergic to milk proteins should not take Tudorza Pressair. Tudorza Pressair should also not be used with other anticholinergic-containing medications.
Before starting treatment with Tudorza Pressair, patients should talk to their doctor about all medications (prescription and over-the-counter), herbal supplements, and vitamins they are taking. Patients should tell their doctor if they are pregnant or plan to become pregnant. It is not known if Tudorza Pressair can harm an unborn baby.
The recommended dose of Tudorza Pressair is one oral inhalation of 400mcg, twice daily. Each dose should be taken about 12 hours apart.